In order to investigate whether BET inhibition affects the tumor-initiating ability of EPN SC cultures, we assessed the expression of previously defined neural cancer SC markers (PROM1, NES and SOX2) and of the astrocytic marker GFAP in the cells treated with OTX015. The gene discussed is GFAP; the disease is neoplasm.